Fully automated analysis of cardiotoxicity surveillance echocardiograms: A direct test-retest precision comparison with experts

Clicks: 1
ID: 325819
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #47 of 47 articles by views in European Heart Journal - Imaging Methods and Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Aims Serial imaging demands measurement precision – particularly for cardiotoxicity screening where small changes gatekeeper major management decisions. Automated measurement using artificial intelligence (AI)-based techniques should reduce variability and increase confidence for detection of true interval change. We directly compared the precision of fully-automated AI versus expert manual analysis of left ventricular function by echocardiography. Methods and Results Consecutive cancer patients referred for cardiotoxicity monitoring underwent same day repeat 2D echocardiography (n=60, 83% female, mean age 52±12years, mean LVEF 57±7%), with 3D acquisition where feasible (n=45). All 2D images underwent blinded manual analysis by fully automated analysis software and four individual experts. Quantitative 2D LVEF measurement was feasible in 97% scans by both methods. Mean absolute difference (MAD) between repeat scans was significantly lower for AI than experts for both 2D LVEF (3.6% [CI 2.8–4.4] vs 6.6% [CI 5.3–7.9], p=0.011) and global longitudinal strain (1.5% [CI 1.1–1.9] vs 2.5% [CI 2.0–3.0], p=0.006). In participants with 3DE datasets, 3D LVEF MAD was lower than manual 2D LVEF (3.6% [CI 2.8-4.6] vs 6.4% [CI 5.0-8.0], p=0.006) but comparable to AI-derived 2D LVEF (3.5% [CI 2.9-4.2], p=0.4). In a subset (n=48) also with same day cardiovascular magnetic resonance studies (CMR), AI 2DE analysis demonstrated stronger agreement with CMR than expert 2DE analysis (LVEF MAD 5.0% [CI 4.1-5.9] vs 7.8% ([CI 6.6-9.0] p=0.006). Conclusions In cancer patients at risk of cardiotoxicity, the precision of 2D echocardiographic AI analysis exceeds that of experts, matching that of 3D LVEF assessment.
Reference Key
openalex_W7203887816 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Benjamin Dowsing, Katia Menacho, Verónica Culotta, Benjamin Meredith, Beth Unsworth, Adam Ioannou, Anish Bhuva, Rhodri Davies, Ana Ferreira, Arjun Ghosh, Mark Westwood, Leon Menezes, Marianna Fontana, Guy Lloyd, Matthew Shun-Shin, James C Moon, Charlotte Manisty
Journal European Heart Journal - Imaging Methods and Practice
Year 2026
DOI
10.1093/ehjimp/qyag142
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.